Furthermore, treatment with 740Y-P to activate the PI3K/AKT signaling decreased TRIM21 expression while treatment with LY294002 to inhibit the PI3K/AKT signaling increased TRIM21 expression in CRC cells (P<0.05, Figure 7B). This evidence concerns the gene AKT1 and colorectal carcinoma.